Recurrence of bone cyst · children with simple bone cysts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Success rate (radiographically‐assessed healing of cyst healing based on the Neer/Cole rating system) · children with simple bone cysts
It is very uncertain whether bone marrow changes success rate (radiographically‐assessed healing of cyst healing… compared with steroid injections (very low certainty).
1 finding from 1 review
Function: ASK function score Clinical record Scale from: 0 to 100 (best outcome) · children with simple bone cysts
1 finding from 1 review
Adverse event: pathological fracture Clinical record · children with simple bone cysts
It is very uncertain whether bone marrow changes adverse event: pathological fracture Clinical record compared with steroid injections (very low certainty).
1 finding from 1 review
Adverse event: infection Clinical record · children with simple bone cysts
It is very uncertain whether bone marrow changes adverse event: infection Clinical record compared with steroid injections (very low certainty).
1 finding from 1 review
Unacceptable malunion · children with simple bone cysts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Oucher pain score Clinical record Scale from: 0 to 100 (maximum pain) · children with simple bone cysts
1 finding from 1 review
All‐cause mortality ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes all‐cause mortality ( compared with control (very low certainty).
1 finding from 1 review
Reduction in pain Various scales including VAS, PISQ; scales ranged from 0 to 4/10/100, where 0 = no pain ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
Amputation · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes incidence of amputation ( compared with control (very low certainty).
1 finding from 1 review
Angiographic analysis · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Increase in ABI An ABI ratio of 0.9 or less indicates PAD. Values between 0.9 and 1.0 are borderline, and above 1.0 is considered normal ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
Increase in PFWD (m) ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
Complications and side effects · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes side effects and complications ( compared with control (very low certainty).
1 finding from 1 review
Tumour response rate Defined as number of complete responses (i.e. disappearance of active Hodgkin lymphoma (gallium negative, ≥ 70% decrease in the sum of the products of the perpendicular diameters of measurable lesions, and negative bone marrow... · children with cancer receiving anthracyclines
Dexrazoxane showed no clear difference in tumour response rate Defined as number of complete responses (i.e.… compared with no cardioprotective intervention (low certainty).
1 finding from 1 review
Intervention not reported
Bone marrow suppression · Patients with quiescent ulcerative colitis
It is very uncertain whether the intervention changes bone marrow suppression (very low certainty).
1 finding from 1 review
Adverse events ‐ arrest of bone marrow · patients with oesophageal cancer
Active cancer therapy combined with TCM probably leads to lower adverse events ‐ arrest of bone marrow compared with active cancer therapy (moderate certainty).
1 finding from 1 review
Intervention not reported
Overall survival (at 36 months) · patients after allogeneic stem cell or bone marrow transplantation
The intervention showed no clear difference in overall survival (at 36 months) (moderate certainty).
1 finding from 1 review
Intervention not reported
Acute GVHD II to IV (90 days) · patients after allogeneic stem cell or bone marrow transplantation
The intervention leads to lower acute GVHD II to IV (90 days) (high certainty).
1 finding from 1 review
Intervention not reported
Overall Chronic GVHD (up to 36 months) · patients after allogeneic stem cell or bone marrow transplantation
The intervention leads to lower overall Chronic GVHD (up to 36 months) (high certainty).
1 finding from 1 review